| Literature DB >> 25844286 |
Michel Kanas1, Hugo Kunzle1, Delio E Martins1, Luiz A Kirsch2, Eduardo B Puertas1, Marcelo Wajchenberg1.
Abstract
Study Design Case report. Objective The purpose of this report is to discuss the management of a disk herniation during pregnancy and the indication and particularities of surgery in this situation. Methods We describe a case of diskectomy performed in a 35-year-old woman at 18 weeks of gestation. After 4 weeks of trying to manage the disk herniation with rest and medications without success, the muscle strength of the L5 right root decreased to grade 4, and the patient was not responding to intravenous analgesia. After discussion with the patient and family, a decision was made to perform the diskectomy. Results After surgery, the patient's pain lessened, and the Lasegue test became negative. Two weeks after the procedure, the patient's muscle strength was normal. In the 40th week of pregnancy, the patient gave birth without any complications. Conclusion When necessary, diskectomy can be indicated and performed during pregnancy. However, appropriate precautions must be taken. Awareness of these precautions is important for the success of the procedure and for the well-being of the mother and the newborn.Entities:
Keywords: anesthesia; intervertebral disk displacement; pregnancy complications
Year: 2014 PMID: 25844286 PMCID: PMC4369201 DOI: 10.1055/s-0034-1387178
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Fig. 1Magnetic resonance image: sagittal view on the left and axial view on the right, demonstrating the L4–L5 disk extrusion with caudal migration compressing the L5 right nerve.
Fig. 2Intraoperative photo demonstrating the patient positioned over cushions to prevent abdominal compression.
Food and Drug Administration risk classification for drug use in pregnancy
| A | Controlled studies in women did not show fetal or maternal risk in any period. |
| B | Controlled studies in animals did not show fetal risk, and there are no controlled studies in women. No evidence of risk in humans. |
| C | Controlled studies in animals did show adverse effects, but there are no controlled studies in humans. These drugs should be given only if the potential benefit justifies the potential risk to the fetus, but the risk cannot be ruled out. |
| D | Positive evidence of human fetal risk exists. However, the benefits of use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed for a life-threatening condition or for a serious disease for which safer drugs cannot be used or are ineffective). |
| X | Contraindicated in pregnancy. Studies in animals or humans have demonstrated fetal abnormalities, or evidence of fetal risk exists based on human experience, or both, and the risk to pregnant women clearly outweighs any possible benefit. These drugs are contraindicated in women who are or may become pregnant. |
Adapted from Friedman JM. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs. Teratology 1993;48:5–6.20
Main drugs used for disk herniation treatment
| Drugs | Type | Class | Observation |
|---|---|---|---|
| Acetaminophen | Nonopioid analgesic | B | More than 4 g/d, for a long period, class D |
| Codeine/tramadol | Opioid analgesics | C | Risks of respiratory tract malformation and hypospadias in the 1st trimester |
| Diclofenac/ibuprofen | Nonsteroidal anti-inflammatory drug | B | Class D in the 3rd trimester; potential for causing premature closure of the ductus arteriosus |
| Prednisone/prednisolone | Glucocorticoids | C/D | In the 1st trimester, can cause cleft lip and palate |
| Cyclobenzaprine | Muscle relaxant | B | Compatible |
| Pregabalin | Anticonvulsant | C | No controlled studies in humans |
Adapted from Kulay L Jr. Medicamentos na gravidez e lactação. 3rd ed. São Paulo, Brazil: Editora Manole; 2012.21